MARKET

VIR

VIR

Vir Biotechnology, Inc.
NASDAQ
13.65
+1.44
+11.75%
Pre Market: 13.57 -0.08 -0.55% 05:59 11/10 EST
OPEN
13.15
PREV CLOSE
12.21
HIGH
14.38
LOW
13.00
VOLUME
2.08K
TURNOVER
0
52 WEEK HIGH
14.38
52 WEEK LOW
5.22
MARKET CAP
2.34B
P/E (TTM)
-10.8664
1D
5D
1M
3M
1Y
5Y
1D
Vir Biotechnology Price Target Raised to $24.00/Share From $20.00 by Needham
Dow Jones · 2h ago
Vir Biotechnology Is Maintained at Buy by Needham
Dow Jones · 2h ago
Vir Biotechnology (VIR) Posts Positive Phase 3 HDV Data With Durable Follow Through
Simply Wall St · 14h ago
Vir Biotechnology, Inc. Reports 44% Response Rate in Phase 3 ECLIPSE 1 Trial and Week 96 SOLSTICE Data
NASDAQ · 15h ago
Healthcare Stocks Rally: EDSA And DCTH Jump 30%, VIR And IMVT Also Gain
NASDAQ · 15h ago
Vir Biotechnology Price Target Maintained With a $22.00/Share by HC Wainwright & Co.
Dow Jones · 18h ago
HC Wainwright & Co. Reiterates Buy on Vir Biotechnology, Maintains $22 Price Target
Benzinga · 18h ago
Vir Biotech Highlights Significant Viral Suppression in Advanced Liver Disease Study
Benzinga · 19h ago
More
About VIR
Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing medicines for serious infectious diseases and cancer. Its portfolio includes programs for chronic hepatitis delta and multiple dual-masked T-cell engagers (TCEs) across validated targets in solid tumor indications. It also has a portfolio of preclinical programs across a range of infectious diseases and oncologic malignancies. Its key product candidates include Elebsiran (VIR-2218); Tobevibart (VIR-3434); VIR-5818; VIR-5525, and VIR-5500. These molecules leverage the PRO-XTEN masking technology with TCEs targeting CD3 on T-cells and HER2, PSMA and EGFR, respectively, on tumor cells. Elebsiran is an investigational hepatitis B virus (HBV)-targeted small interfering RNA that reduces hepatitis B surface antigen (HBsAg). Tobevibart is an investigational neutralizing monoclonal antibody that has been engineered for immune engagement and targets a conserved region on the HBsAg.

Webull offers Vir Biotechnology Inc stock information, including NASDAQ: VIR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VIR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VIR stock methods without spending real money on the virtual paper trading platform.